Pediatric Vaccines Market Size, Share, Growth Analysis, By Type(Monovalent, Multivalent), By Technology(Live Attenuated, Inactivated, Subunit, Toxoid), By Application(Infectious Disease, Cancer, Allergy), By Region(North America, The U.S., Canada, Europe) - Industry Forecast 2024-2031

The market for Pediatric Vaccines was estimated to be valued at US$ XX Mn in 2021.

The Pediatric Vaccines Market is estimated to grow at a CAGR of XX% by 2028.

The Pediatric Vaccines Market is segmented on the basis of Type, Technology, Application, Region.

Based on region, the Pediatric Vaccines Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Pediatric Vaccines Market are mainly focus on expanding their product portfolio and invest in mergers and acquisitions to capture a larger revenue share. For instance, GlaxoSmithKline plc, in 2015, acquired the vaccine business division of Novartis and received approval for two new vaccines-Infanrix and Boostrix, which provide immunization against diphtheria, tetanus, and pertussis. , KEY MARKET SEGMENTS , By Type , Monovalent , Multivalent , By Technology , Live Attenuated , Inactivated , Subunit , Toxoid , Conjugate , Others , By Application , Infectious Disease , Cancer , Allergy , By Region , North America , The U.S. , Canada , Europe , Germany , U.K. , Asia Pacific , China , Japan , India , Latin America , Middle East & Africa , KEY PLAYERS , GlaxoSmithKline plc , Merck Sharp & Dohme Corp. , SANOFI , AstraZeneca , Pfizer, Inc. , Zydus Cadila , Indian Immunologicals Limited , Serum Institute of India Pvt. Ltd. , Mitsubishi Tanabe Pharma Corporation , Panacea Biotec , Sinovac Biotech Ltd. , Bio Med Pvt. Ltd. .